I Had the Same Rare Pancreatic Cancer as Steve Jobs

Health and medicine explained.
Oct. 6 2011 11:04 AM

Steve Jobs and Me

A layman’s guide to islet-cell tumors in the pancreas.

(Continued from Page 1)

In contrast to my own tumor, there are five types of "functional" islet-cell tumors. They "present" in a variety of ways, depending on what kind of hormones they produce: insulinomas, which can cause low blood sugar; gastrinomas, which release large amounts of gastrin, a hormone, into the bloodstream and cause ulcers in the stomach and duodendum; VIPomas, which tend to cause severe diarrhea; glucagonomas, which cause severe skin rashes and weight loss, among other symptoms; and somatostatinomas, extremely rare (fewer than one in 40 million people get them) islet-cell tumors with "nonspecific" clinical symptoms including diabetes and stones in the gallbladder. We have no way of knowing what was causing Jobs' "hormone imbalance," but functioning islet-cell tumors do all produce hormones, so this is one plausible explanation.

After I was diagnosed, I was told that modern medicine doesn't have chemotherapy or radiation to use against islet cells. ("We've got nothing that works" went the refrain.) Islet-cell tumors tend to be slow-growing, so chemotherapy designed to attack rapidly growing cells is ineffective. But there are some drugs, including one called streptozocin, that have "response rates as high as 70%" with islet-cells, according to Hopkins' Web page. In some cases, doctors can also use techniques such as hepatic artery embolization and chemoembolization, which essentially destroy the blood vessels that have been feeding the metastases in an attempt to choke off the tumors' blood supply.

Advertisement

We as a country have shortchanged medical research regarding both adenocarcinoma of the pancreas and islet-cell tumors. For starters, the National Cancer Institute has been cutting grants for adenocarcinoma research in recent years, and the funding stream for scientists is drying up. This is happening at the very moment when doctors at the Sol Goldman Pancreatic Cancer Research Center have mapped the pancreatic cancer genetic blueprint—opening up a promising new field of research and possibly new early detection tests and treatments.

At the same time, as with many rarer diseases, pharmaceutical companies have little financial incentive to support scientific research into islet-cell tumors, while the government also shortchanges research into uncommon diseases. "The greatest emphasis is paid to funding the most common tumors, such as those of the lung, breast and colon. When you consider the pitiful federal funding for pancreatic adenocarcinoma, despite this cancer claiming over 34,000 American lives each year, you can imagine where even less common cancers like islet-cell tumors fit into the grand scheme of things," says Dr. Anirban Maitra, an associate professor of pathology and oncology at Johns Hopkins. "Unless there is a commitment to study rare diseases like islet cell tumors, there is unlikely to be significant progress in this disease."

Video: Steve Wozniak Remembers Steve Jobs

Furthermore, "[A]dvances made in pancreatic adenocarcinoma—and there have been some significant ones, funded by nonfederal dollars—are highly unlikely to be extrapolated to islet cell tumors, simply because they are essentially completely different tumors joined only by the commonality of occurring in the pancreas. It, too, is a major medical orphan."

One professor of oncology and pathology at Hopkins, Bert Vogelstein, has said that if he can find a donor who will support the project, he and his team will do their best to sequence the islet-cell tumor genome within a year. Perhaps, if Jobs' recent medical woes turn out to be related to his islet-cell tumor, there will be greater attention paid to the disease, the way Michael J. Fox helped increase awareness of Parkinson's. If I've learned nothing else since my diagnosis, it's that medical orphans need attention, too.

TODAY IN SLATE

War Stories

The Right Target

Why Obama’s airstrikes against ISIS may be more effective than people expect.

Why Is This Mother in Prison for Helping Her Daughter Get an Abortion?

The XX Factor
Sept. 23 2014 11:13 AM Why Is This Mother in Prison for Helping Her Daughter Get an Abortion?

Divestment Is Fine but Mostly Symbolic. There’s a Better Way for Universities to Fight Climate Change.

I Stand With Emma Watson on Women’s Rights

Even though I know I’m going to get flak for it.

It Is Very Stupid to Compare Hope Solo to Ray Rice

Building a Better Workplace

In Defense of HR

Startups and small businesses shouldn’t skip over a human resources department.

It’s Legal for Obama to Bomb Syria Because He Says It Is

How Ted Cruz and Scott Brown Misunderstand What It Means to Be an American Citizen

  News & Politics
War Stories
Sept. 23 2014 4:04 PM The Right Target Why Obama’s airstrikes against ISIS may be more effective than people expect.
  Business
Moneybox
Sept. 23 2014 2:08 PM Home Depot’s Former Lead Security Engineer Had a Legacy of Sabotage
  Life
Outward
Sept. 23 2014 1:57 PM Would a Second Sarkozy Presidency End Marriage Equality in France?
  Double X
The XX Factor
Sept. 23 2014 2:32 PM Politico Asks: Why Is Gabby Giffords So “Ruthless” on Gun Control?
  Slate Plus
Political Gabfest
Sept. 23 2014 3:04 PM Chicago Gabfest How to get your tickets before anyone else.
  Arts
Brow Beat
Sept. 23 2014 4:45 PM Why Is Autumn the Only Season With Two Names?
  Technology
Future Tense
Sept. 23 2014 5:36 PM This Climate Change Poem Moved World Leaders to Tears Today
  Health & Science
Science
Sept. 23 2014 4:33 PM Who Deserves Those 4 Inches of Airplane Seat Space? An investigation into the economics of reclining.
  Sports
Sports Nut
Sept. 18 2014 11:42 AM Grandmaster Clash One of the most amazing feats in chess history just happened, and no one noticed.